SANKYO/PARKE-DAVIS JOINT VENTURE TO PROMOTE ACCUPRIL ACE INHIBITOR AND TROGLITAZONE ANTIDIABETIC; PROVIDES PLATFORM FOR FUTURE SANKYO LAUNCHES IN U.S.

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".